Metabolix, Inc.

YTENQ Basic Materials Agricultural Inputs

Metabolix, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $60,000.00, down 86.7% from fiscal 2022. Operating cash flow growth for three consecutive years.

0.00 0.00 NaN
Market cap
$1.5M
P/E
0.0×
Fwd P/E
−0.1×
Dividend yield
—
F-score
2/9
Altman Z
−161.45
Beneish M
n/a
Dividend safety
n/a
Older periods Sep '23 Dec '23 Mar '24 Jun '24
ROE

+8 more TTM periods

(380.77%) (1,508.09%) 1,211.52% 449.55%
Piotroski F-Score
— — 3 —
ROA
(167.40%) (241.08%) (274.51%) (287.44%)
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(483,066.67%) 495.54% 365.14% 210.54%
Average Days of Receivables
— — 0.00 0.00
Free Cash Flow per Share
(30.54) (30.53) (16.00) (9.03)
Free Cash Flow
(11.44) (10.11) (8.30) (5.80)
Capital Expenditures
(0.03) (0.05) — —
Other line items
Cash ROIC
(356.65%) 714.77% 483.92% 105.34%
Accounts Receivable Turnover
— — 0.00 0.00
Accounts Payable Turnover
2.04 0.00 0.00 0.00
Inventory Turnover
0.00 — — —
Average Days of Payables
280.94 0.00 0.00 0.00
Days of Inventory on Hand
0.00 — — —
Tax Rate
0.01 0.00 0.00 0.00
Research and Development Expense of Revenue
0.00% 0.00% 1,348.92% 800.33%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 1,044.80% 687.18%
Share Based Compensation of Revenue
0.00% 0.00% 279.39% 168.12%
Operating CF/Net income
0.79 0.70 0.63 0.46
Depreciation/Fixed assets
0.48 0.53 0.59 0.63
Capex/Depreciation
(0.09) (0.16) 0.00 0.00
Revenue per Share
0.00 0.00 1.08 1.40
Operating CF per Share
(30.47) (30.39) (16.00) (9.03)
Capex per Share
(0.07) (0.14) 0.00 0.00
Capex to Sales
0.00 0.00 0.00 0.00

Fold the line items

Columns are period end dates